Education
About Us
Working with TipRanks
Follow Us
Alfresa Holdings Corporation (ARHCF)
OTHER OTC:ARHCF
ARHCF Stock Chart & Stats
$16.18
$0.00(0.00%)
At close: 4:00 PM EDT
$16.18
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$10.55 - $18.89
Previous CloseN/A
Volume871.00
Average Volume (3M)0.00
Market Cap
$3.15B
Enterprise Value$279.40B
Total Cash (Recent Filing)$180.61B
Total Debt (Recent Filing)$30.60B
Price to Earnings (P/E)5.4
Beta0.17
Next Earnings
May 19, 2026EPS Estimate
0.24Next Dividend Ex-DateN/A
Dividend Yield3.56%
Share Statistics
EPS (TTM)0.72
Shares Outstanding191,300,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-3.35
Price to Book (P/B)0.81
Price to Sales (P/S)0.13
P/FCF Ratio-36.06
Enterprise Value/Market Cap88.57
Enterprise Value/Revenue0.09
Enterprise Value/Gross Profit1.30
Enterprise Value/Ebitda5.79
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.18
Revenue Forecast (FY)$20.08B
Bulls Say, Bears Say
Bulls Say
Balance Sheet Strength / Low LeverageVery low leverage and a solid equity ratio give Alfresa durable financial flexibility. This supports working-capital needs in distribution, reduces solvency risk, and allows the firm to fund logistics or buy-in opportunities without overreliance on external debt.
Consistent Revenue GrowthSteady top-line growth around the mid-single digits indicates persistent demand for pharmaceutical distribution services. Predictable revenue helps sustain scale economics, supports long-term contracts with customers, and underpins incremental margin improvement via density of logistics operations.
Resilient Business Model And Scale In Healthcare DistributionAlfresa's role as a high-volume intermediary and provider of logistics/inventory services creates recurring revenue streams and customer stickiness. Scale in distribution is a durable competitive advantage, enabling negotiating power with suppliers and efficiency gains across fulfillment.
Bears Say
Weak Cash Conversion / Negative Free Cash FlowA sharp deterioration in free cash flow and low operating-cash-flow-to-net-income ratio highlight difficulty converting earnings into spendable cash. For a working-capital intensive wholesaler, this constrains reinvestment, limits debt capacity usage, and heightens funding risk for growth or dividends.
Thin Profitability MarginsVery low absolute margins leave limited buffer versus cost inflation, reimbursement changes, or pricing pressure. Small adverse shifts in procurement costs or customer pricing can materially compress earnings, challenging sustainable reinvestment and long-run earnings volatility control.
Modest Return On EquityAn ROE in the mid-single digits suggests modest profit generation from shareholder capital. Combined with thin margins and negative free cash flow, this may limit capacity to deliver strong returns to investors or to self-fund higher-return growth initiatives over the medium term.
Alfresa Holdings News
ARHCF FAQ
What was Alfresa Holdings Corporation’s price range in the past 12 months?
Alfresa Holdings Corporation lowest stock price was $10.55 and its highest was $18.89 in the past 12 months.
What is Alfresa Holdings Corporation’s market cap?
Alfresa Holdings Corporation’s market cap is $3.15B.
When is Alfresa Holdings Corporation’s upcoming earnings report date?
Alfresa Holdings Corporation’s upcoming earnings report date is May 19, 2026 which is in 75 days.
How were Alfresa Holdings Corporation’s earnings last quarter?
Alfresa Holdings Corporation released its earnings results on Feb 10, 2026. The company reported $0.716 earnings per share for the quarter, beating the consensus estimate of $0.417 by $0.3.
Is Alfresa Holdings Corporation overvalued?
According to Wall Street analysts Alfresa Holdings Corporation’s price is currently Overvalued.
Does Alfresa Holdings Corporation pay dividends?
Alfresa Holdings Corporation pays a Semiannually dividend of $0.234 which represents an annual dividend yield of 3.56%. See more information on Alfresa Holdings Corporation dividends here
What is Alfresa Holdings Corporation’s EPS estimate?
Alfresa Holdings Corporation’s EPS estimate is 0.24.
How many shares outstanding does Alfresa Holdings Corporation have?
Alfresa Holdings Corporation has 191,300,000 shares outstanding.
What happened to Alfresa Holdings Corporation’s price movement after its last earnings report?
Alfresa Holdings Corporation reported an EPS of $0.716 in its last earnings report, beating expectations of $0.417. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Alfresa Holdings Corporation?
Currently, no hedge funds are holding shares in ARHCF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Alfresa Holdings Corporation
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.
Technical Analysis
Medipal Holdings
―
Sundrug Co
―
Sugi Holdings Co
―
Suzuken Co
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―
Ownership Overview
―
Insiders
5.04% Mutual Funds
― Other Institutional Investors
87.47% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---